Dambkowski Carl sold APGE
August 6, 2025 · Form 4 insider transaction
Dambkowski Carl sold 2,725 shares of Apogee Therapeutics Inc at $37.78 per share, a transaction worth $103.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,725
Price
$37.78
Total value
$103.0K
InsiderDambkowski Carl
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 6, 2025
Filing dateAugust 8, 2025
Shares owned after236,273
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on August 21, 2024.